Company / R&D Expense
Beta Bionics, Inc. R&D Expense History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$34.8M
FY2025
5-year range
$17.9M / $34.8M
FY2023-FY2025
Trend
+32.9%
vs FY2024
Sector context
#92 of 110
Health Care
What the data says
Beta Bionics, Inc.'s r&d expense of $35M is lower than 84% of companies in the Health Care sector (FY2025). Improved from $18M to $35M over the past 2 years.
Based on SEC 10-K filings.
$35M in FY2025.
Improved from $18M to $35M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 110This company $34.8M Sector average $298.2M
▼
-88.3% below sector average
Key checks
Key Insights
- In FY2025, r&d expense increased 32.9% year-over-year.
- Ranks #92 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.8M | +32.9% |
| FY2024 | $26.2M | +45.9% |
| FY2023 | $17.9M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026